Both P-gp and MRP contribute to drug resistance in AML

Leukemia. 1998 Aug;12(8):1327-8. doi: 10.1038/sj.leu.2401096.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / physiology*
  • ATP-Binding Cassette Transporters / physiology*
  • Acute Disease
  • Antineoplastic Agents / pharmacokinetics
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm
  • Fluoresceins / pharmacokinetics
  • Fluorescent Dyes / pharmacokinetics
  • Humans
  • In Vitro Techniques
  • Leukemia, Myeloid / drug therapy*
  • Multidrug Resistance-Associated Proteins
  • Neoplasm Proteins / physiology*

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • ATP-Binding Cassette Transporters
  • Antineoplastic Agents
  • Fluoresceins
  • Fluorescent Dyes
  • Multidrug Resistance-Associated Proteins
  • Neoplasm Proteins
  • calcein AM